Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumour associated with poor 5-year survival. We aimed to determine factors which differentiate short and long-term survivors and identify a prognostic biomarker. METHODS: Over a ten-year period, patients with resected PDAC who devel...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Gall, Tamara M.H., Gerrard, Gareth, Frampton, Adam E., Castellano, Leandro, Ahmad, Raida, Habib, Nagy, Spalding, Duncan, Pai, Madhava, Foroni, Letizia, Jiao, Long R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2019
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6366827/
https://ncbi.nlm.nih.gov/pubmed/30774772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26511
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky